Skip to main content
logo
Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,490.00
-390.00 (-3.95%)
At close: Feb 6, 2026

Revenue by Product

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Cancer Immunotherapy Drugs
1.90B
Cancer Immunotherapy Drugs Growth
13737.27%

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
South Korea
1.90B
South Korea Growth
13737.27%